Daniëlle Krijgsman obtained her PhD at Leiden University Medical Center in collaboration with Aarhus University, where she studied tumor–immune interactions in colorectal cancer, with a particular focus on the roles of NK cells and macrophages as prognostic markers through their surface and secreted factors. During her postdoctoral training at the University Medical Center Utrecht, she investigated the contribution of diverse myeloid cell populations to therapy resistance across different cancer types, applying spatial proteomics to dissect their functions in the tumor microenvironment. She is currently a junior principal investigator at the Center for Translational Immunology, University Medical Center Utrecht. Her research centers on innate immunity as a therapeutic target in both cancer and autoimmune diseases, with projects ranging from myeloid cell–based immunotherapy in colorectal cancer to complement inhibition strategies in neuroinflammatory disorders.